Next Article in Journal
Genetic Variants in Human Leukocyte Antigen-DP Influence Both Hepatitis C Virus Persistence and Hepatitis C Virus F Protein Generation in the Chinese Han Population
Previous Article in Journal
Preparation and Enzymatic Degradation of Porous Crosslinked Polylactides of Biomass Origin
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2014, 15(6), 9809-9825; doi:10.3390/ijms15069809

Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity

1
Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove CZ-50001, Czech Republic
2
Karel English College in Brno, Sujanovo namesti 356/1, Brno 60200, Czech Republic 
Received: 5 February 2014 / Revised: 6 March 2014 / Accepted: 11 March 2014 / Published: 2 June 2014
(This article belongs to the Section Molecular Toxicology)
View Full-Text   |   Download PDF [434 KB, uploaded 19 June 2014]   |  

Abstract

Acetylcholinesterase (AChE) inhibitors are widely used for the symptomatic treatment of Alzheimer’s disease and other dementias. More recent use is for myasthenia gravis. Many of these inhibitors interact with the second known cholinesterase, butyrylcholinesterase (BChE). Further, evidence shows that acetylcholine plays a role in suppression of cytokine release through a “cholinergic anti-inflammatory pathway” which raises questions about the role of these inhibitors in the immune system. This review covers research and discussion of the role of the inhibitors in modulating the immune response using as examples the commonly available drugs, donepezil, galantamine, huperzine, neostigmine and pyridostigmine. Major attention is given to the cholinergic anti-inflammatory pathway, a well-described link between the central nervous system and terminal effector cells in the immune system. View Full-Text
Keywords: cholinergic anti-inflammatory pathway; acetylcholinesterase; butyrylcholinesterase; Alzheimer disease; neuroimmunity; neuromodulation cholinergic anti-inflammatory pathway; acetylcholinesterase; butyrylcholinesterase; Alzheimer disease; neuroimmunity; neuromodulation
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Pohanka, M. Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity. Int. J. Mol. Sci. 2014, 15, 9809-9825.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top